Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Waseem F"'
Publikováno v:
Iraqi Journal of Hematology, Vol 12, Iss 1, Pp 28-32 (2023)
BACKGROUND: Hodgkin lymphoma (HL) is an aggressive B-cell lymphoma, considered one of the most curable hematological malignancies. Hasenclever International Prognostic Score was designed to predict 5-year freedom from the progression of HL. D-dimer i
Externí odkaz:
https://doaj.org/article/7a57207120ae4b1b91d45e2359ce7b4b
Publikováno v:
Iraqi Journal of Hematology, Vol 11, Iss 1, Pp 32-37 (2022)
BACKGROUND: Some of the platelet count disorders have no single clinical or laboratory diagnostic finding and bone marrow examination may be required which is invasive, time consuming. Platelet indices are readily available parameters by recent hemat
Externí odkaz:
https://doaj.org/article/816cc4f53ce245258fe86b5a7d1acc98
Publikováno v:
Clinical eHealth, Vol 4, Iss , Pp 67-73 (2021)
Coronaviruses are enveloped non-segmented positive-sense RNA viruses belonging to the family Coronaviridae. The human coronavirus infections are mild; the epidemics of the two β-coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV)
Externí odkaz:
https://doaj.org/article/57c47264431447d19e714c194585c371
Publikováno v:
Journal of Applied Hematology, Vol 12, Iss 4, Pp 189-194 (2021)
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is representing 30%–40% of all lymphomas. It is an aggressive lymphoma with heterogeneous clinicopathological features. Inflammatory processes have been identified to play an important role in the p
Externí odkaz:
https://doaj.org/article/e04301a6cc334d49acfef2c9b2c2184a
Publikováno v:
Iraqi Journal of Hematology, Vol 8, Iss 2, Pp 74-80 (2019)
BACKGROUND: Polycythemia vera (PV) is a chronic myeloproliferative stem cell disease usually combined with JAK2 mutation. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation. Such
Externí odkaz:
https://doaj.org/article/525a1f74857644cd9cce21e5f14a5474
Autor:
Hussein Ali Al-Toban, Huda Dhaher Al-Marsomy, Waseem F Al-Tameemi, Asmaa Baqer Al-Obaidi, Mazen Abbas Mohammed, Raghad Majid Al-Saeed, Ibrahim Khalil Al-Shemary
Publikováno v:
Iraqi Journal of Hematology, Vol 8, Iss 1, Pp 38-44 (2019)
BACKGROUND: Acute leukemia and allogenic bone marrow transplantation BMT are immunocompromised conditions which may be susceptible for many opportunistic infections or reactivation of latent infections like Toxoplasma gondii (T.gondii). OBJECTIVES: T
Externí odkaz:
https://doaj.org/article/b37ea07c49f4461eac7e844677d169e6
Publikováno v:
Iraqi Journal of Hematology, Vol 7, Iss 1, Pp 8-13 (2018)
Background: The morbidity and mortality in polycythemia vera (PV) are closely associated with cardiovascular diseases burden and clonal evolution. These complications were primarily attributed to abnormal rheology consequent to the raised hematocrit,
Externí odkaz:
https://doaj.org/article/594036e66ea64775961e996ac10c73c7
Publikováno v:
Journal of Applied Hematology, Vol 9, Iss 1, Pp 16-21 (2018)
Background: The sickling process of sickle cell disease (SCD) has harmful effects on the vascular endothelium manifested as vascular blockade, diminished tissue oxygenation, and consequently reperfusion injury. Statins pleiotropic effects can be demo
Externí odkaz:
https://doaj.org/article/5a08a257fcc748d98f03040ac617858c
Autor:
Sammer A Najjar, Waseem F Al Tameemi
Publikováno v:
Iraqi Journal of Hematology, Vol 6, Iss 1, Pp 6-11 (2017)
Background: Multiple myeloma (MM) is a clonal proliferation of malignant plasma cells in the bone marrow that produced monoclonal protein, and associated with different organ dysfunction. β2 Microglubulin is a known prognostic marker while CRP is pr
Externí odkaz:
https://doaj.org/article/74fff38314294b19bc5611ae1ccb3db5
Autor:
Waseem F Al Tameemi
Publikováno v:
Iraqi Journal of Hematology, Vol 4, Iss 1, Pp 1-15 (2015)
Background: Chronic lymphocytic leukemia (CLL) remains an incurable disease with variable course. It is typically responsive to several courses of chemotherapy. Objectives: Evaluation of efficacy of combination of rituximab with chlorambucil plus pre
Externí odkaz:
https://doaj.org/article/1619e29d3c7d43de9698f411902b5b6e